BioMarin Pharmaceutical Inc. buy Canaccord Genuity Group Inc.
Start price
22.05.26
/
50%
€46.24
Target price
22.05.27
€95.52
Performance (%)
24.52%
Price
17.08.26
€57.58
Summary
This prediction is currently active. The BUY prediction by Canaccord_Genuity_Gr currently has a performance of 24.52%. This prediction currently runs until 22.05.27. The prediction end date can be changed by Canaccord_Genuity_Gr at any time. Canaccord_Genuity_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| BioMarin Pharmaceutical Inc. | -3.551% | -3.551% |
| iShares Core DAX® | -0.046% | 5.960% |
| iShares Nasdaq 100 | 0.922% | 3.693% |
| iShares Nikkei 225® | 3.014% | 6.638% |
| iShares S&P 500 | -0.359% | 2.747% |
Comments by Canaccord_Genuity_Gr for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical (BMRN) had its price target lowered by Canaccord Genuity Group Inc. from $116.00 to $111.00. They now have a "buy" rating on the stock.
Ratings data for BMRN provided by MarketBeat
Stopped prediction by Canaccord_Genuity_Gr for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€56.96
10.08.26
10.08.26
€98.67
10.08.27
10.08.27
1.09%
17.08.26
17.08.26
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€51.78
26.02.26
26.02.26
€87.99
26.02.27
26.02.27
11.20%
17.08.26
17.08.26